Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.
Ludwik KA, Campbell JP, Li M, Li Y, Sandusky ZM, Pasic L, Sowder ME, Brenin DR, Pietenpol JA, O'Doherty GA, Lannigan DA.
Ludwik KA, et al. Among authors: li y, li m.
Mol Cancer Ther. 2016 Nov;15(11):2598-2608. doi: 10.1158/1535-7163.MCT-16-0106. Epub 2016 Aug 15.
Mol Cancer Ther. 2016.
PMID: 27528706
Free PMC article.